Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers
Drug Metabolism and Disposition · 2025-07 · 53 (7) · 100091
DOI: 10.1016/j.dmd.2025.100091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025-07. Verfasst von Severin Mairinger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; Department of Biomedical Imaging and Image-Guided Therapy, Medica…. Hauptthemen laut MEDLINE: Diclofenac, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Universität Wien, Ministry of Science and ICT, South Korea, Korea Institute of Radiological & Medical Sciences.
Abstract (Originalsprache)
An important safety consideration for topically administered drugs is the extent of systemic exposure they achieve. The aim of this study was to evaluate whether a topically administered microdose of the model drug diclofenac can predict the systemic availability, plasma, and tissue pharmacokinetics of a topical therapeutic dose. Eight healthy participants (6 men and 2 women) participated in a 4-period, crossover study. In period 1, a topical microdose (62 ± 6 μg) was administered; in period 2, a single intravenous microdose (0.95 ± 0.03 μg) was administered; in period 3, a topical therapeutic dose (120 mg) was administered; and in period 4, a single intravenous therapeutic dose (75 mg) of [14C]diclofenac was administered, with or without the addition of unlabeled diclofenac. Venous blood, urine, and microdialysis samples from subcutaneous adipose tissue beneath the dermal application site were collected for 24 h post-dosing. Total 14C-concentrations in plasma and microdialysates were quantified using accelerator mass spectrometry. The disposition of intravenously administered [14C]diclofenac was dose-linear. However, after topical administration, the fraction of total 14C absorbed (geometric mean and 95% confidence interval) was higher (P = .0019, 2-tailed, paired t test) for the microdose (0.48% and 0.34%-0.67%) compared with the therapeutic dose (0.13% and 0.07%-0.22%) (geometric mean ratio and 90% confidence interval: 3.79 and 2.41-5.98). Dose-normalized 14C-concentrations in microdialysates were low, variable, and did not differ between doses. Our study demonstrates the feasibility of quantifying 14C-concentrations in plasma and microdialysates following the topical administration of a microdose of [14C]diclofenac. The observed nonlinearity in systemic availability after topical dosing suggests that microdosing may not accurately predict the disposition of certain topical drugs at therapeutic doses. SIGNIFICANCE STATEMENT: We assessed whether a topically applied microdose of diclofenac could predict the systemic availability of a therapeutic dose. Results showed that systemic absorption was not dose-linear, indicating that microdosing may have limited use for predicting the pharmacokinetics of some topical drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
- Korea Radio-Isotope Center for Pharmaceuticals, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea.
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- Korea Radio-Isotope Center for Pharmaceuticals, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea. Electronic address: jinho1120@kirams.re.kr.
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. Electronic address: oliver.la…
Förderung
- Medizinische Universität Wien
- Ministry of Science and ICT, South Korea
- Korea Institute of Radiological & Medical Sciences
- Servier
Zitieren
APA
Mairinger, S., Kwon, M., Bauer, M., Song, J., Lackner, E., Jorda, A., Bergmann, F., Minichmayr, I. K., Kim, K. Y., Choi, M. S., Shim, J. H., Dueker, S. R., Zeitlinger, M., & Langer, O. (2025). Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers. Drug Metabolism and Disposition, 53(7), 100091. https://doi.org/10.1016/j.dmd.2025.100091
Vancouver
Mairinger S, Kwon M, Bauer M, Song J, Lackner E, Jorda A, et al. Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers. Drug Metabolism and Disposition. 2025;53(7):100091. doi:10.1016/j.dmd.2025.100091
BibTeX
@article{Mairinger2025,
author = {Mairinger, Severin and Kwon, Mihye and Bauer, Martin and Song, Jinho and Lackner, Edith and Jorda, Anselm and Bergmann, Felix and Minichmayr, Iris K and Kim, Ka Yeon and Choi, Min Sun and Shim, Jae Hoon and Dueker, Stephen R and Zeitlinger, Markus and Langer, Oliver},
title = {Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers},
journal = {Drug Metabolism and Disposition},
year = {2025},
volume = {53},
number = {7},
pages = {100091},
doi = {10.1016/j.dmd.2025.100091}
}
EUVIMED